Literature DB >> 4199801

Molecular pathology of ceruloplasmin.

S A Neifakh, I M Vasiletz, M M Shavlovsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4199801     DOI: 10.1007/bf00486406

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


× No keyword cloud information.
  15 in total

1.  CHROMATOGRAPHIC AND MAGNETIC STUDIES ON HUMAN CERULOPLASMIN.

Authors:  L BROMAN
Journal:  Acta Soc Med Ups       Date:  1964

2.  COMPENSATORY EFFECTS IN THE SYNTHESIS OF HEMOGLOBIN POLYPEPTIDE CHAINS.

Authors:  E ZUCKERKANDL
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1964

3.  Studies on the biochemical characterization of human ceruloplasmin.

Authors:  S B Needleman; V Sahgal; B Boshes
Journal:  Experientia       Date:  1970-05-15

4.  [Peptide maps of reduced carboxymethylated human ceruloplasmin].

Authors:  M M Shavlovskiĭ; I M Vasilets
Journal:  Biokhimiia       Date:  1970 Sep-Oct

5.  Electrophoretic variation in human serum ceruloplasmin: a new genetic polymorphism.

Authors:  D C Shreffler; G J Brewer; J C Gall; M S Honeyman
Journal:  Biochem Genet       Date:  1967-09       Impact factor: 1.890

6.  [Synthesis of ceruloplasmin by liver slices from monkeys].

Authors:  A M Shaposhnikov; N K Monakhov
Journal:  Biokhimiia       Date:  1968 Mar-Apr

7.  [Organ and intracellular localization of the biosynthesis of ceruloplasmin].

Authors:  A M Shaposhnikov; Iu N Zubzhitskiĭ; G V Mukha
Journal:  Biokhimiia       Date:  1968 May-Jun

8.  Identification of ceruloplasmin in human liver cells by fluorescent antibodies and absence of this protein in Wilson disease.

Authors:  A M Shaposhnikov; Y N Zubzitski; V S Shulman
Journal:  Experientia       Date:  1969-04-15

9.  Localization of ceruloplasmin biosynthesis in human and monkey liver cells and its copper regulation.

Authors:  S A Neifakh; N K Monakhov; A M Shaposhnikov; Y N Zubzhitski
Journal:  Experientia       Date:  1969-04-15

10.  Ceruloplasmin in Wilson's disease.

Authors:  N A Holtzman; M A Naughton; F L Iber; B M Gaumnitz
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

View more
  5 in total

1.  On the defect of synthesis ceruloplasmin in the liver polyribosomes in Wilson's disease.

Authors:  V S Gaitskhoki; O I Kisselev; K A Moshkov; L V Puchkova; M M Shavlovski; V S Shulman; V G Vacharlovski; S A Neifakh
Journal:  Biochem Genet       Date:  1975-10       Impact factor: 1.890

2.  Isolation and partial purification of ceruloplasmin messenger RNA from rat liver.

Authors:  S A Neifakh; V S Gaitskhoki; N A Klimov; L V Puchkova; M M Shavlovski; A L Schwartzman
Journal:  Mol Biol Rep       Date:  1977-03       Impact factor: 2.316

3.  Molecular studies of ceruloplasmin deficiency in Wilson's disease.

Authors:  M J Czaja; F R Weiner; S J Schwarzenberg; I Sternlieb; I H Scheinberg; D H Van Thiel; N F LaRusso; M A Giambrone; R Kirschner; M L Koschinsky
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Preproceruloplasmin is a primary product of cell-free translation of ceruloplasmin messenger RNA.

Authors:  L V Puchkova; V S Gaitskhoki; N K Monakhov; L T Timchenko; S A Neifakh
Journal:  Mol Cell Biochem       Date:  1981-03-27       Impact factor: 3.396

5.  Highly purified ceruloplasmin messenger RNA from rat liver. Physico-chemical and functional characteristics.

Authors:  V S Gaitskhoki; V M L'vov; L V Puchkova; A L Schwartzman; S A Neifakh
Journal:  Mol Cell Biochem       Date:  1981-03-27       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.